A Phase2, Open, Random, Mulicentre Trial To Assess The Efficacy And Tolerability of Intravenous ZD9331 Given As Monotherapy (at Two Doses) Or In Combination With Toptecan, In Patients With Ovarian Cancer Refractory Or Recurrent After ...

  • Poole, Christopher (Principal Investigator)

Project Details

Short titleA Phase2, Open, Random, Mulicentre Trial To Assess The Efficacy And Tolerability of Intravenous ZD9331 Given As Monotherapy (at Two Doses) Or In Combination With Toptecan, In Patients With Ovarian Cancer Refractory Or Recurrent After ...
StatusFinished
Effective start/end date1/03/01 → 28/02/03

Funding

  • ASTRA ZENECA UK LIMITED